Corporate Therapeutic Sessions
These company-based information sessions will provide attendees with non-CME educational opportunities to learn the latest in therapeutics.
Teva Neurosciences, Teva Pharmaceuticals Industries, H. Lundbeck A/S
Sunday, June 22
10:30-12:00
Grand Ballroom
Issues and Controversies in Parkinson's Disease
| Chair: | C. Warren Olanow New York, NY, USA |
Search for Diagnostic Tools and pre-motor diagnosis of Parkinson's Disease
Matt Stern
Philadelphia, PA, USA
Trial Design and changing strategies
Karl Kieburtz
Rochester, NY, USA
Review of Azilect early and adjunct
Oliver Rascol
Toulouse, France
EMD Serono Inc.
Monday, June 23
16:30 - 17:30
Grand Ballroom
Behind the mask of Parkinson's Disease
| Chair: | Paolo Barone Napoli, Italy |
Chair: |
Anthony Schapira London, United Kingdom |
Is it time to re-think Parkinson's Disease?
Anthony Schapira
London, United Kingdom
The meaning of cognitive impairment and related disorders in the understanding of Parkinson's Disease progression
Paolo Barone
Napoli, Italy
Assessing drug effects in Parkinson's Disease: a multifaceted approach beyond UPDRS
Jaime Kulisevsky
Barcelona, Spain
Solvay Pharmaceuticals
Monday, June 23
16:30-17:30
Continental Ballroom
Continuous intra-duodenal infusion of levodopa / carbidopa in the treatment of advanced Parkinson's Disease
| Chair: | Jens Volkmann Kiel, Germany |
Current concepts on the role of dopamine in the normal basal ganglia: implications for Parkinson's Disease therapy
C. Warren Olanow
New York, NY, USA
Duodenal levodopa infusion: from theory to clinical practice
Angelo Antonini
Monza, Italy
Boehringer Ingelheim Pharmaceuticals, Inc.
Monday, June 23
18:00-19:00
Grand Ballroom
The Continuum of Parkinson's Disease Treatment and Effect on Activities of Daily Living
| Chair: | Matt Stern Philadelphia, PA, USA |
Current Concepts in Early Treatment of Parkinson's Disease
Anthony Schapira
London, United Kingdom
Treatment of Advanced Parkinson's Disease
Werner Poewe
Innsbruck, Austria
The Evolution of Disability in Parkinson's Disease
Lisa M. Shulman
Baltimore, MD, USA
Vernalis Pharmaceuticals, Inc.
Monday, June 23
18:00-19:00
Continental Ballroom
Clinical and Practical Considerations in the Acute Management of "Off" Episodes in Advanced Parkinson's Disease
| Chair: | Kapil Sethi Augusta, GA, USA |
Clinical Considerations in the acute management of "off" episodes
Stewart A. Factor
Atlanta, GA, USA
Practical Considerations in the acute management of "off" episodes
William Ondo
Houston, TX, USA
GlaxoSmithKline
Monday, June 23
19:30-20:30
Continental Ballroom
Advances in the Management and Treatment of Parkinson's Disease
| Chair: | Ray Watts Birmingham, AL, USA |
Lecture - Current Trends and Medical Developments
Panel Discussions - Patient Case Studies
Rajesh Pahwa
Kansas City, KS, USA
Fabrizio Stocchi
Roma, Italy
Mark Stacy
Durham, NC, USA
Bonnie Hersh
Chestnut Hill, MA, USA